SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-630877
Filing Date
2016-06-24
Accepted
2016-06-24 09:20:58
Documents
6
Period of Report
2016-06-24
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d209119d8k.htm 8-K 35467
2 EX-3.1 d209119dex31.htm EX-3.1 11365
3 EX-3.2 d209119dex32.htm EX-3.2 35187
4 EX-4.1 d209119dex41.htm EX-4.1 13373
5 EX-4.2 d209119dex42.htm EX-4.2 13550
6 EX-99.1 d209119dex991.htm EX-99.1 11793
  Complete submission text file 0001193125-16-630877.txt   122626
Mailing Address 1020 E. MEADOW CIRCLE PALO ALTO CA 94303
Business Address 1020 E. MEADOW CIRCLE PALO ALTO CA 94303 650-543-7500
Anacor Pharmaceuticals, Inc. (Filer) CIK: 0001411158 (see all company filings)

IRS No.: 251854385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34973 | Film No.: 161729999
SIC: 2834 Pharmaceutical Preparations